Abstract
ObjectiveTo evaluate the value of post-treatment follow-up in osteosarcoma patients.MethodsData were collected through a clinical record, with socio-demographic and clinical data, and information relating to the medical appointment. Descriptive analysis of the data was carried out. The Chi-squared test was used to associate the independent variables with attendance at scheduled follow-up appointments.ResultsWe found a recurrence in 59.6% of cases, of which 58% were lung related; 44% presented clinical complaints and arrived on the scheduled date of the appointment. There was no statistically significant association between the demographic characteristics and early attendance of follow-up visits. 81.3% of the cases who came for the appointment earlier than originally scheduled presented complaints compared to those who did not (p=0.005). Of the cases who presented recurrence, 12.9% attended an appointment late and those who did not present recurrence, 47.6% were late for the appointment (p=0.006).ConclusionIt is seen that the patients who came for an earlier appointment presented more complaints and were associated with the positive result of the exams carried out. The patients who had recurrence and came for an earlier appointment did not present a statistically significant difference in recurrence-free survival. It was observed that distance was not a predominant factor in late attendance at appointments. Level of Evidence II, Retrospective Study.
Highlights
As regards disease-free survival, the time was evaluated between the end of treatment and the appearance of recurrence, emphasizing that only patients without metastasis at the beginning of the study were considered for this analysis
In the sample that encompassed eight Brazilian states, namely São Paulo, Rondônia, Minas Gerais, Mato Grosso, Mato Grosso do Sul, Goiás, Alagoas and Piauí, 48.1% of the patients came from the state of São Paulo
Some of the main hypotheses for the expressiveness at Hospital de Câncer de Barretos (HCB) in relation to the number of patients enrolled in the trial are the reference of the orthopedic oncology team, easy access to the scheduling of new cases and the prevention program established by HCB, which reaches faraway states, such as Rondônia, which is the state with the second highest patient origin percentages in the study
Summary
As regards disease-free survival, the time was evaluated between the end of treatment and the appearance of recurrence, emphasizing that only patients without metastasis at the beginning of the study were considered for this analysis.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
